Therapix Biosciences Ltd (TRPX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current TRPX market cap is 223.8k. The company's latest EPS is USD -7.2550 and P/E is -0.04.
| Quarter End | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.13M | -1.65M | -1.73M | -1.85M | -1.25M |
| Net Income | -2.05M | -1.21M | -1.74M | -2.14M | -493k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 1.35M | 2.88M |
| Operating Income | -4.11M | -2.55M | -5.77M | -8.4M | -7.03M |
| Net Income | -4.48M | -3.48M | -5.79M | -2.59M | -5.12M |
| Quarter End | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.06M | 6.39M | 5.06M | 4.57M | 2.08M |
| Total Liabilities | 1.56M | 1.23M | 1.45M | 5.42M | 2.82M |
| Total Equity | 6.5M | 5.15M | 3.61M | -850k | -742k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.15M | 2.56M | 9.92M | 10.61M | 11.18M |
| Total Liabilities | 1.14M | 1.13M | 1.78M | 4.16M | 1.6M |
| Total Equity | 14k | 1.43M | 8.14M | 6.45M | 9.59M |
| Quarter End | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.63M | -1.84M | -900k | N/A | -2.89M |
| Investing | -9k | -503k | -1.64M | N/A | 1.27M |
| Financing | -37k | 1,000 | N/A | N/A | 1.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.7M | -4.31M | -5.06M | -7.92M | -5.89M |
| Investing | 1.27M | 24k | -70k | -7.08M | -1.11M |
| Financing | 2.8M | 5.36M | 10.06M | 11.7M | 5.5M |
| Market Cap | 223.8k |
| Price to Earnings Ratio | -0.04 |
| Price to Sales Ratio | 0.07 |
| Price to Cash Ratio | 0.09 |
| Price to Book Ratio | 0.02 |
| Dividend Yield | - |
| Shares Outstanding | 706k |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (1.56%) |
| Company Name | Therapix Biosciences Ltd |
| Address |
20 raul wallenberg st., tower a, 2nd floor tel aviv, center 6971916 |
| Website | https://scisparc.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
